nodes	percent_of_prediction	percent_of_DWPC	metapath
Amobarbital—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.219	0.312	CbGbCtD
Amobarbital—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.219	0.312	CbGbCtD
Amobarbital—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.166	0.237	CbGbCtD
Amobarbital—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0973	0.139	CbGbCtD
Amobarbital—CHRNA7—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00809	0.0492	CbGpPWpGaD
Amobarbital—CHRNA4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00775	0.0471	CbGpPWpGaD
Amobarbital—CHRNA4—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA3—chronic obstructive pulmonary disease	0.00772	0.0469	CbGpPWpGaD
Amobarbital—CHRNA7—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.00667	0.0406	CbGpPWpGaD
Amobarbital—CHRNA4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0066	0.0401	CbGpPWpGaD
Amobarbital—CHRNA7—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0066	0.0401	CbGpPWpGaD
Amobarbital—CHRNA4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00632	0.0384	CbGpPWpGaD
Amobarbital—CHRNA4—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00615	0.0374	CbGpPWpGaD
Amobarbital—CHRNA4—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.00544	0.0331	CbGpPWpGaD
Amobarbital—CHRNA7—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.00544	0.0331	CbGpPWpGaD
Amobarbital—CHRNA4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00538	0.0327	CbGpPWpGaD
Amobarbital—CHRNA4—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00502	0.0305	CbGpPWpGaD
Amobarbital—CHRNA4—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.00443	0.027	CbGpPWpGaD
Amobarbital—CHRNA4—Nicotine Activity on Dopaminergic Neurons—CHRNA5—chronic obstructive pulmonary disease	0.00393	0.0239	CbGpPWpGaD
Amobarbital—CHRNA4—Nicotine Activity on Dopaminergic Neurons—CHRNA3—chronic obstructive pulmonary disease	0.00321	0.0195	CbGpPWpGaD
Amobarbital—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.00308	0.0231	CcSEcCtD
Amobarbital—Thinking abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00273	0.0205	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00268	0.0201	CcSEcCtD
Amobarbital—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.00259	0.0195	CcSEcCtD
Amobarbital—Nightmare—Salbutamol—chronic obstructive pulmonary disease	0.00241	0.0181	CcSEcCtD
Amobarbital—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.00226	0.017	CcSEcCtD
Amobarbital—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00224	0.0168	CcSEcCtD
Amobarbital—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00221	0.0166	CcSEcCtD
Amobarbital—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.00218	0.0164	CcSEcCtD
Amobarbital—Mental disability—Salbutamol—chronic obstructive pulmonary disease	0.00217	0.0163	CcSEcCtD
Amobarbital—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00208	0.0156	CcSEcCtD
Amobarbital—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00193	0.0145	CcSEcCtD
Amobarbital—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.0128	CcSEcCtD
Amobarbital—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00159	0.012	CcSEcCtD
Amobarbital—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00153	0.0115	CcSEcCtD
Amobarbital—GABRA6—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00151	0.00919	CbGpPWpGaD
Amobarbital—GABRA4—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00149	0.00907	CbGpPWpGaD
Amobarbital—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00149	0.0112	CcSEcCtD
Amobarbital—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00148	0.0111	CcSEcCtD
Amobarbital—CYP2A6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.0014	0.0085	CbGpPWpGaD
Amobarbital—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.0105	CcSEcCtD
Amobarbital—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00137	0.0103	CcSEcCtD
Amobarbital—GABRA6—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00135	0.00819	CbGpPWpGaD
Amobarbital—GABRA4—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00133	0.00809	CbGpPWpGaD
Amobarbital—GABRA5—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00133	0.00806	CbGpPWpGaD
Amobarbital—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00984	CcSEcCtD
Amobarbital—GABRA3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0013	0.00792	CbGpPWpGaD
Amobarbital—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00973	CcSEcCtD
Amobarbital—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.00969	CcSEcCtD
Amobarbital—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00129	0.00966	CcSEcCtD
Amobarbital—GABRA2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00128	0.00778	CbGpPWpGaD
Amobarbital—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00126	0.00946	CcSEcCtD
Amobarbital—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00123	0.00924	CcSEcCtD
Amobarbital—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.00917	CcSEcCtD
Amobarbital—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00889	CcSEcCtD
Amobarbital—GABRA5—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00118	0.00719	CbGpPWpGaD
Amobarbital—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00881	CcSEcCtD
Amobarbital—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.0088	CcSEcCtD
Amobarbital—CYP2A6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00117	0.00711	CbGpPWpGaD
Amobarbital—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00875	CcSEcCtD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00116	0.00707	CbGpPWpGaD
Amobarbital—GABRA3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00116	0.00706	CbGpPWpGaD
Amobarbital—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00871	CcSEcCtD
Amobarbital—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00865	CcSEcCtD
Amobarbital—GABRA2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00114	0.00694	CbGpPWpGaD
Amobarbital—Tension—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00853	CcSEcCtD
Amobarbital—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00853	CcSEcCtD
Amobarbital—CYP2A6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00112	0.00684	CbGpPWpGaD
Amobarbital—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00844	CcSEcCtD
Amobarbital—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00844	CcSEcCtD
Amobarbital—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00111	0.0083	CcSEcCtD
Amobarbital—GABRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00109	0.00663	CbGpPWpGaD
Amobarbital—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00805	CcSEcCtD
Amobarbital—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00799	CcSEcCtD
Amobarbital—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00799	CcSEcCtD
Amobarbital—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00797	CcSEcCtD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00106	0.00643	CbGpPWpGaD
Amobarbital—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00794	CcSEcCtD
Amobarbital—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00794	CcSEcCtD
Amobarbital—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00782	CcSEcCtD
Amobarbital—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00778	CcSEcCtD
Amobarbital—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00102	0.00618	CbGpPWpGaD
Amobarbital—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00754	CcSEcCtD
Amobarbital—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.001	0.00752	CcSEcCtD
Amobarbital—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000998	0.0075	CcSEcCtD
Amobarbital—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000982	0.00737	CcSEcCtD
Amobarbital—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000982	0.00737	CcSEcCtD
Amobarbital—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000981	0.00737	CcSEcCtD
Amobarbital—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00098	0.00736	CcSEcCtD
Amobarbital—GABRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.000973	0.00591	CbGpPWpGaD
Amobarbital—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000961	0.00722	CcSEcCtD
Amobarbital—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00096	0.00721	CcSEcCtD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000948	0.00576	CbGpPWpGaD
Amobarbital—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000927	0.00696	CcSEcCtD
Amobarbital—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000914	0.00687	CcSEcCtD
Amobarbital—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.000911	0.00554	CbGpPWpGaD
Amobarbital—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000908	0.00682	CcSEcCtD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000889	0.00541	CbGpPWpGaD
Amobarbital—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000882	0.00663	CcSEcCtD
Amobarbital—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000882	0.00663	CcSEcCtD
Amobarbital—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000877	0.00659	CcSEcCtD
Amobarbital—GRIK2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000874	0.00531	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000862	0.00524	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000862	0.00524	CbGpPWpGaD
Amobarbital—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000862	0.00647	CcSEcCtD
Amobarbital—CYP2A6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00085	0.00517	CbGpPWpGaD
Amobarbital—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000839	0.00631	CcSEcCtD
Amobarbital—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000839	0.00631	CcSEcCtD
Amobarbital—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000833	0.00626	CcSEcCtD
Amobarbital—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000822	0.00618	CcSEcCtD
Amobarbital—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00082	0.00616	CcSEcCtD
Amobarbital—CYP2A6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000817	0.00497	CbGpPWpGaD
Amobarbital—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000807	0.00607	CcSEcCtD
Amobarbital—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000807	0.00607	CcSEcCtD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000795	0.00483	CbGpPWpGaD
Amobarbital—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000793	0.00595	CcSEcCtD
Amobarbital—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000789	0.00593	CcSEcCtD
Amobarbital—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000782	0.00588	CcSEcCtD
Amobarbital—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000782	0.00587	CcSEcCtD
Amobarbital—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000778	0.00584	CcSEcCtD
Amobarbital—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000778	0.00584	CcSEcCtD
Amobarbital—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000777	0.00584	CcSEcCtD
Amobarbital—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000774	0.00581	CcSEcCtD
Amobarbital—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000762	0.00573	CcSEcCtD
Amobarbital—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000746	0.00561	CcSEcCtD
Amobarbital—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000746	0.00561	CcSEcCtD
Amobarbital—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000744	0.00559	CcSEcCtD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000739	0.0045	CbGpPWpGaD
Amobarbital—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000738	0.00554	CcSEcCtD
Amobarbital—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000737	0.00554	CcSEcCtD
Amobarbital—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000737	0.00554	CcSEcCtD
Amobarbital—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000735	0.00552	CcSEcCtD
Amobarbital—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000733	0.00551	CcSEcCtD
Amobarbital—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000733	0.0055	CcSEcCtD
Amobarbital—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000731	0.00549	CcSEcCtD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00073	0.00444	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000725	0.00441	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000712	0.00433	CbGpPWpGaD
Amobarbital—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000705	0.00529	CcSEcCtD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000703	0.00427	CbGpPWpGaD
Amobarbital—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000696	0.00523	CcSEcCtD
Amobarbital—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000696	0.00523	CcSEcCtD
Amobarbital—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000695	0.00522	CcSEcCtD
Amobarbital—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000681	0.00512	CcSEcCtD
Amobarbital—GRIK2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00067	0.00407	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000668	0.00406	CbGpPWpGaD
Amobarbital—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000657	0.00493	CcSEcCtD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000651	0.00396	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000649	0.00394	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000648	0.00394	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000648	0.00394	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000637	0.00387	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000626	0.00381	CbGpPWpGaD
Amobarbital—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000624	0.00469	CcSEcCtD
Amobarbital—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000624	0.00469	CcSEcCtD
Amobarbital—Secobarbital—CYP1A2—chronic obstructive pulmonary disease	0.000614	0.41	CrCbGaD
Amobarbital—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000612	0.00459	CcSEcCtD
Amobarbital—CHRNA7—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000609	0.0037	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000603	0.00366	CbGpPWpGaD
Amobarbital—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.0006	0.00451	CcSEcCtD
Amobarbital—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.0006	0.00451	CcSEcCtD
Amobarbital—Rash—Formoterol—chronic obstructive pulmonary disease	0.000595	0.00447	CcSEcCtD
Amobarbital—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000595	0.00447	CcSEcCtD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000595	0.00362	CbGpPWpGaD
Amobarbital—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000595	0.00447	CcSEcCtD
Amobarbital—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000595	0.00447	CcSEcCtD
Amobarbital—Headache—Formoterol—chronic obstructive pulmonary disease	0.000592	0.00444	CcSEcCtD
Amobarbital—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000592	0.00444	CcSEcCtD
Amobarbital—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00059	0.00443	CcSEcCtD
Amobarbital—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00442	CcSEcCtD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000588	0.00357	CbGpPWpGaD
Amobarbital—Rash—Montelukast—chronic obstructive pulmonary disease	0.000583	0.00438	CcSEcCtD
Amobarbital—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000583	0.00438	CcSEcCtD
Amobarbital—Headache—Montelukast—chronic obstructive pulmonary disease	0.000579	0.00435	CcSEcCtD
Amobarbital—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000573	0.0043	CcSEcCtD
Amobarbital—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000567	0.00426	CcSEcCtD
Amobarbital—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000562	0.00422	CcSEcCtD
Amobarbital—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000562	0.00422	CcSEcCtD
Amobarbital—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000562	0.00422	CcSEcCtD
Amobarbital—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000561	0.00421	CcSEcCtD
Amobarbital—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000561	0.00421	CcSEcCtD
Amobarbital—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000559	0.0042	CcSEcCtD
Amobarbital—GABRA6—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000556	0.00338	CbGpPWpGaD
Amobarbital—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000551	0.00414	CcSEcCtD
Amobarbital—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000549	0.00413	CcSEcCtD
Amobarbital—GABRA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000549	0.00334	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000546	0.00332	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000545	0.00331	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000534	0.00325	CbGpPWpGaD
Amobarbital—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000532	0.004	CcSEcCtD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000531	0.00323	CbGpPWpGaD
Amobarbital—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00053	0.00398	CcSEcCtD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000529	0.00322	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000528	0.00321	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000526	0.0032	CbGpPWpGaD
Amobarbital—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00052	0.00391	CcSEcCtD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000519	0.00316	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000519	0.00316	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000512	0.00311	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00051	0.0031	CbGpPWpGaD
Amobarbital—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000503	0.00378	CcSEcCtD
Amobarbital—CHRNA7—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000497	0.00302	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000497	0.00302	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000488	0.00297	CbGpPWpGaD
Amobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000486	0.00295	CbGpPWpGaD
Amobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000479	0.00291	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000479	0.00291	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000479	0.00291	CbGpPWpGaD
Amobarbital—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000476	0.00289	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000471	0.00286	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000469	0.00285	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000463	0.00281	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000462	0.00281	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000453	0.00276	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000453	0.00276	CbGpPWpGaD
Amobarbital—Phenobarbital—CYP1A1—chronic obstructive pulmonary disease	0.00045	0.3	CrCbGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000447	0.00272	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000445	0.00271	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000435	0.00265	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000435	0.00265	CbGpPWpGaD
Amobarbital—Phenobarbital—CYP1A2—chronic obstructive pulmonary disease	0.000434	0.29	CrCbGaD
Amobarbital—GABRA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000426	0.00259	CbGpPWpGaD
Amobarbital—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000421	0.00317	CcSEcCtD
Amobarbital—GABRA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000421	0.00256	CbGpPWpGaD
Amobarbital—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000418	0.00314	CcSEcCtD
Amobarbital—GRIA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000417	0.00254	CbGpPWpGaD
Amobarbital—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000416	0.00313	CcSEcCtD
Amobarbital—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000411	0.0025	CbGpPWpGaD
Amobarbital—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000408	0.00307	CcSEcCtD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000407	0.00248	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000405	0.00246	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000404	0.00246	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000401	0.00244	CbGpPWpGaD
Amobarbital—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.0004	0.00301	CcSEcCtD
Amobarbital—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000398	0.00242	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000397	0.00241	CbGpPWpGaD
Amobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000394	0.00239	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00039	0.00237	CbGpPWpGaD
Amobarbital—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000386	0.0029	CcSEcCtD
Amobarbital—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000384	0.00233	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00038	0.00231	CbGpPWpGaD
Amobarbital—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000377	0.00283	CcSEcCtD
Amobarbital—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000374	0.00227	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000367	0.00223	CbGpPWpGaD
Amobarbital—Shock—Prednisone—chronic obstructive pulmonary disease	0.000366	0.00275	CcSEcCtD
Amobarbital—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000361	0.00219	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00036	0.00219	CbGpPWpGaD
Amobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000353	0.00214	CbGpPWpGaD
Amobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000348	0.00212	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000347	0.00211	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000343	0.00208	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000338	0.00206	CbGpPWpGaD
Amobarbital—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000338	0.00254	CcSEcCtD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000332	0.00202	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000329	0.002	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000327	0.00199	CbGpPWpGaD
Amobarbital—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000322	0.00242	CcSEcCtD
Amobarbital—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000322	0.00242	CcSEcCtD
Amobarbital—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.00241	CcSEcCtD
Amobarbital—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000318	0.00239	CcSEcCtD
Amobarbital—CYP2A6—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00031	0.00188	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000307	0.00187	CbGpPWpGaD
Amobarbital—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000306	0.0023	CcSEcCtD
Amobarbital—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000305	0.00185	CbGpPWpGaD
Amobarbital—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000304	0.00228	CcSEcCtD
Amobarbital—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000299	0.00182	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000297	0.0018	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000294	0.00179	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000294	0.00179	CbGpPWpGaD
Amobarbital—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000294	0.00221	CcSEcCtD
Amobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000286	0.00174	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000284	0.00172	CbGpPWpGaD
Amobarbital—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000274	0.00206	CcSEcCtD
Amobarbital—CYP2A6—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000269	0.00163	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000264	0.0016	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000252	0.00153	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000251	0.00152	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000249	0.00151	CbGpPWpGaD
Amobarbital—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000246	0.00185	CcSEcCtD
Amobarbital—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00177	CcSEcCtD
Amobarbital—Rash—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00176	CcSEcCtD
Amobarbital—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00176	CcSEcCtD
Amobarbital—Headache—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00175	CcSEcCtD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000223	0.00135	CbGpPWpGaD
Amobarbital—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00166	CcSEcCtD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000214	0.0013	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000209	0.00127	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000206	0.00125	CbGpPWpGaD
Amobarbital—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000201	0.00122	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000199	0.00121	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000196	0.00119	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000183	0.00111	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000182	0.00111	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000182	0.0011	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000181	0.0011	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000174	0.00106	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000174	0.00106	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00016	0.000974	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000155	0.000943	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.000924	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000147	0.000897	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000126	0.000768	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000125	0.000761	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000122	0.000743	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000112	0.000683	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000108	0.000656	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000103	0.000627	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000102	0.00062	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000102	0.00062	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	9.13e-05	0.000555	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.05e-05	0.00055	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.89e-05	0.000541	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.74e-05	0.000531	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.1e-05	0.000492	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	7.88e-05	0.000479	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.82e-05	0.000476	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.45e-05	0.000453	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	7.45e-05	0.000453	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.32e-05	0.000445	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.31e-05	0.000384	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.2e-05	0.000377	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.12e-05	0.000372	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.44e-05	0.000331	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.34e-05	0.000325	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.25e-05	0.000319	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.47e-05	0.000272	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.3e-05	0.000262	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	4.25e-05	0.000259	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	3.88e-05	0.000236	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.58e-05	0.000217	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.98e-05	0.000181	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.94e-05	0.000179	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.74e-05	0.000167	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.6e-05	0.000158	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	1.77e-05	0.000107	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.69e-05	0.000103	CbGpPWpGaD
